People

Nanonization company Nanoform has named former Hovione Senior Project Manager Miguel Cansado as Director of Project Management. Cansado is the third former Hovione employee to join Nanoform this year, following the appointments of Miguel Calado as Vice Chairman of the Board and Gonçalo Rebelo de Andrade as Chief of Business Operations. Cansado said, “I am very … [Read more...] about Nanoform appoints Miguel Cansado as Director of Project Management

Robert Clarke is stepping down as CEO of DPI developer Pulmatrix and will be succeeded immediately by current Chief Business Officer Ted Raad, the company said. Clarke, who was appointed CEO in 2012, will stay on through August 14, 2019 as an advisor. Clarke said, "After fifteen years at Pulmatrix growing with the organization from Head of R&D to CSO and … [Read more...] about Robert Clarke steps down as Pulmatrix CEO

Nanoform has announced the appointment of former GSK Particle Size Reduction Lead David Rowe as Head of Manufacturing. In December 2018, the Finnish nanotechnology company announced the construction of a new GMP manufacturing facility in Helsinki. Rowe is the latest in a series of new hires by Nanoform over the past few months, including former Hovione Business … [Read more...] about Nanoform appoints David Rowe as Head of Manufacturing

Neurelis, which submitted an NDA for its Valtoco diazepam nasal spray in September 2018, has announced the appointments of a number of senior management personnel in anticipation of a launch. The appointments announced took place from late 2017 to 2019. The hires include George Stuart as Chief Financial Officer, Chuck DeWildt as Chief Commercial Officer, Adrian … [Read more...] about Neurelis adds senior management personnel in anticipation of Valtoco nasal spray launch

Finnish particle engineering company Nanoform has named former Hovione executive Miguel Calado as Vice Chairman of the Board. In addition to having served as CFO and VP of Finance of Hovione, Calado has also been CFO of PepsiCo International and President of International Operations at Dean Foods. Earlier this year, Nanoform named former Hovione Business … [Read more...] about Nanoform names Miguel Calado as Vice Chairman of the Board

Synspira Therapeutics, which is developing an inhaled therapy for cystic fibrosis, has announced the appointment of Robert Gallotto as President and CEO. Gallotto was most recently President and co-founder of Alcresta Therapeutics. He previously co-founded Allena Pharmaceuticals and served in executive positions at Alnara Pharmaceuticals, Altus Pharmaceuticals, and … [Read more...] about Synspira Therapeutics appoints Robert Gallotto as President and CEO

Swedish DPI company Iconovo has announced the appointment of Roger Lassing as Vice President Business Development. Lassing, who was most recently Senior Manager of Global Business Development at LEO Pharma, has previously held executive positions at Takeda, Nycomed, and AstraZeneca, where he was Global Brand Manager for Symbicort. Over the past few years, Iconovo … [Read more...] about Iconovo appoints Roger Lassing as VP Business Development

Acorda Therapeutics has announced the appointment of Peter S. Carbone as Senior VP, Quality. Carbone was most recently VP of Quality Solids Americas & Special Technologies at Novartis and previously held executive positions at Amgen and Allergan. The FDA approved Acorda's Inbrija levodopa DPI for the treatment of OFF episodes in Parkinson’s disease patients in … [Read more...] about Acorda Therapeutics names Peter S. Carbone as Senior VP, Quality

Device company Nemera has announced the promotion of the leader of its Innovation Center, Dimitri Grasswill, to VP of Innovation. Grasswill has directed the Innovation Center, located in La Verpillière, France, since 2013. In a tweet announcing his promotion, Grasswill is quoted as saying "I am proud of leading a passionate and creative team of drug delivery … [Read more...] about Nemera promotes Dimitri Grasswill to VP of Innovation